Follow
Mirjana Efremova
Mirjana Efremova
Group Leader / Barts Cancer Institute
Verified email at qmul.ac.uk
Title
Cited by
Cited by
Year
Pan-cancer immunogenomic analyses reveal genotype-immunophenotype relationships and predictors of response to checkpoint blockade
P Charoentong, F Finotello, M Angelova, C Mayer, M Efremova, D Rieder, ...
Cell reports 18 (1), 248-262, 2017
34652017
CellPhoneDB: inferring cell–cell communication from combined expression of multi-subunit ligand–receptor complexes
M Efremova, M Vento-Tormo, SA Teichmann, R Vento-Tormo
Nature protocols 15 (4), 1484-1506, 2020
21732020
Single-cell reconstruction of the early maternal–fetal interface in humans
R Vento-Tormo, M Efremova, RA Botting, MY Turco, M Vento-Tormo, ...
Nature 563 (7731), 347-353, 2018
18172018
Resolving the fibrotic niche of human liver cirrhosis at single-cell level
P Ramachandran, R Dobie, JR Wilson-Kanamori, EF Dora, ...
Nature 575 (7783), 512-518, 2019
11612019
A survey of tools for variant analysis of next-generation genome sequencing data
S Pabinger, A Dander, M Fischer, R Snajder, M Sperk, M Efremova, ...
Briefings in bioinformatics 15 (2), 256-278, 2014
7852014
A cellular census of human lungs identifies novel cell states in health and in asthma
FA Vieira Braga, G Kar, M Berg, OA Carpaij, K Polanski, LM Simon, ...
Nature medicine 25 (7), 1153-1163, 2019
7832019
Decoding human fetal liver haematopoiesis
DM Popescu, RA Botting, E Stephenson, K Green, S Webb, L Jardine, ...
Nature 574 (7778), 365-371, 2019
4902019
Spatiotemporal immune zonation of the human kidney
BJ Stewart, JR Ferdinand, MD Young, TJ Mitchell, KW Loudon, AM Riding, ...
Science 365 (6460), 1461-1466, 2019
3472019
Developmental cell programs are co-opted in inflammatory skin disease
G Reynolds, P Vegh, J Fletcher, EFM Poyner, E Stephenson, I Goh, ...
Science 371 (6527), eaba6500, 2021
3412021
Targeting immune checkpoints potentiates immunoediting and changes the dynamics of tumor evolution
M Efremova, D Rieder, V Klepsch, P Charoentong, F Finotello, H Hackl, ...
Nature communications 9 (1), 32, 2018
2812018
Single-cell RNA sequencing reveals a dynamic stromal niche that supports tumor growth
S Davidson, M Efremova, A Riedel, B Mahata, J Pramanik, J Huuhtanen, ...
Cell reports 31 (7), 2020
2332020
Neoantigens generated by individual mutations and their role in cancer immunity and immunotherapy
M Efremova, F Finotello, D Rieder, Z Trajanoski
Frontiers in immunology 8, 1679, 2017
2172017
Pancancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade. Cell Rep. 2017; 18: 248–62
P Charoentong, F Finotello, M Angelova, C Mayer, M Efremova, D Rieder, ...
1982010
Computational methods for single-cell omics across modalities
M Efremova, SA Teichmann
Nature methods 17 (1), 14-17, 2020
1832020
Single-cell sequencing reveals clonal expansions of pro-inflammatory synovial CD8 T cells expressing tissue-homing receptors in psoriatic arthritis
F Penkava, MDC Velasco-Herrera, MD Young, N Yager, LN Nwosu, ...
Nature communications 11 (1), 4767, 2020
1392020
Blood and immune development in human fetal bone marrow and Down syndrome
L Jardine, S Webb, I Goh, M Quiroga Londoņo, G Reynolds, M Mather, ...
Nature 598 (7880), 327-331, 2021
922021
Mosquito cellular immunity at single-cell resolution
G Raddi, ABF Barletta, M Efremova, JL Ramirez, R Cantera, ...
Science 369 (6507), 1128-1132, 2020
882020
Immunology in the era of single-cell technologies
M Efremova, R Vento-Tormo, JE Park, SA Teichmann, KR James
Annual Review of Immunology 38 (1), 727-757, 2020
732020
Bioinformatics for cancer immunology and immunotherapy
P Charoentong, M Angelova, M Efremova, R Gallasch, H Hackl, J Galon, ...
Cancer Immunology, Immunotherapy 61, 1885-1903, 2012
672012
Nuclear receptor NR2F6 inhibition potentiates responses to PD-L1/PD-1 cancer immune checkpoint blockade
V Klepsch, N Hermann-Kleiter, P Do-Dinh, B Jakic, A Offermann, ...
Nature communications 9 (1), 1538, 2018
572018
The system can't perform the operation now. Try again later.
Articles 1–20